Guardant Health Income Statement
Revenue, expenses, and profitability over time
Guardant Health generated $1.1B in trailing twelve-month revenue, up 0.4% year-over-year. Net income was -$433.2M with a -40.1% net margin. Gross margin stands at 64.9% and operating margin at -41.43%. Diluted EPS is $-3.39. Based on the Q1 2026 filing.
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$17.2B
ROE200.62%